Yuxiang Ma

机构：Sun Yat-sen University, Sun Yat-sen University Cancer Center

发表论文 11 篇 · 总被引 118 次 · h-index 7

代表论文

• Low Prognostic Nutritional Index Correlates with Worse Survival in Patients with Advanced NSCLC following EGFR-TKIs (2016 · PLoS ONE · 被引 39)
• The Good Pain Management (GPM) Ward Program in China and its impact on Chinese cancer patients: the SYSUCC experience (2014 · 癌症：英文版 · 被引 19)
• Surufatinib plus toripalimab combined with etoposide and cisplatin as first-line treatment in advanced small-cell lung cancer patients: a phase Ib/II trial (2024 · Signal Transduction and Targeted Therapy · 被引 14)
• Multiple oncogenic mutations related to targeted therapy in nasopharyngeal carcinoma (2015 · 癌症：英文版 · 被引 14)
• Early change of plasma Epstein-Barr virus DNA load and the viral lytic genome level could positively predict clinical outcome in recurrent or metastatic nasopharyngeal carcinoma receiving anti-programmed cell death 1 monotherapy (2024 · BMC Cancer · 被引 9)
• QoL analyses from INFORM study, a phase III study of gefitinib versus placebo as maintenance therapy in advanced NSCLC (2015 · Scientific Reports · 被引 8)